Free Trial

Nukkleus (NASDAQ:NUKK) Shares Down 10.1% - Here's Why

Nukkleus logo with Business Services background

Nukkleus Inc. (NASDAQ:NUKK - Get Free Report) dropped 10.1% during mid-day trading on Monday . The company traded as low as $16.50 and last traded at $18.00. Approximately 355,335 shares changed hands during trading, a decline of 75% from the average daily volume of 1,396,463 shares. The stock had previously closed at $20.02.

Analyst Upgrades and Downgrades

Separately, Wall Street Zen raised shares of Nukkleus from a "sell" rating to a "hold" rating in a report on Friday.

Check Out Our Latest Analysis on NUKK

Nukkleus Stock Performance

The stock has a 50 day moving average price of $14.83 and a two-hundred day moving average price of $16.37.

Nukkleus (NASDAQ:NUKK - Get Free Report) last issued its quarterly earnings data on Friday, May 23rd. The company reported $18.19 EPS for the quarter.

Hedge Funds Weigh In On Nukkleus

An institutional investor recently bought a new position in Nukkleus stock. Compagnie Lombard Odier SCmA bought a new position in shares of Nukkleus Inc. (NASDAQ:NUKK - Free Report) during the first quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 6,200 shares of the company's stock, valued at approximately $74,000. Compagnie Lombard Odier SCmA owned approximately 0.13% of Nukkleus as of its most recent SEC filing. 12.47% of the stock is owned by hedge funds and other institutional investors.

Nukkleus Company Profile

(Get Free Report)

Nukkleus Inc, a financial technology company, provides blockchain-enabled technology solutions worldwide. It focuses on providing software and technology solutions for retail foreign exchange trading industry. The company provides transactions platform for dealing and risk management services. It also offers cross-border payment and transactions solutions and blockchain-enabled financial services solutions to institutional investors.

Recommended Stories

Should You Invest $1,000 in Nukkleus Right Now?

Before you consider Nukkleus, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Nukkleus wasn't on the list.

While Nukkleus currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

2025 Gold Forecast: A Perfect Storm for Demand Cover

Unlock the timeless value of gold with our exclusive 2025 Gold Forecasting Report. Explore why gold remains the ultimate investment for safeguarding wealth against inflation, economic shifts, and global uncertainties. Whether you're planning for future generations or seeking a reliable asset in turbulent times, this report is your essential guide to making informed decisions.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

NVIDIA’s Secret Picks? 3 Stocks Rising With the AI Giant
NVIDIA Earnings Preview: HUGE Stock Move Ahead
These 5 Small Stocks Could Deliver Huge Returns

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines